This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Michaele Peters: Innovator in Medical Treatments
Introduction
Michaele Peters is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medical treatments, particularly in addressing conditions such as endometriosis and fibrosis. With a total of 3 patents to her name, her work is recognized for its innovative approach to complex health issues.
Latest Patents
Michaele Peters' latest patents include groundbreaking research on the use of chymase inhibitors for the treatment of endometriosis, postoperative fibrosis, and diseases characterized by fibrosis formation. This application focuses on bicyclic-substituted uracil derivatives, which can be used alone or in combination with other active ingredients to treat inflammatory and fibrotic disorders. Another notable patent involves substituted pyridyl-cycloalkyl-carboxylic acids, which are designed for the treatment or prophylaxis of various pain syndromes, including those associated with endometriosis and adenomyosis.
Career Highlights
Michaele Peters is currently employed at Bayer Pharma Aktiengesellschaft, where she continues to develop her innovative ideas into practical medical solutions. Her work has garnered attention for its potential to improve the quality of life for individuals suffering from chronic pain and related conditions.
Collaborations
Michaele collaborates with esteemed colleagues such as Horst Irlbacher and Marcus Koppitz, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Michaele Peters stands out as a dedicated inventor whose work in medical treatments is paving the way for advancements in healthcare. Her patents reflect a commitment to addressing significant health challenges, and her collaborations enhance the impact of her research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
